HEMOTORIC MINGLEMENT SYSTEMS (HMS) are now being offered to help prevent heart attacks and strokes by measuring the blood pressure of the patient, and if the patient’s blood pressure drops, the system can warn the doctor.
The technology, developed by a company called Hemodynamic Monitoring Systems, can now be used to measure blood pressure in an emergency room.
It is not currently available in all hospitals, and its use is not recommended for patients who have pre-existing heart conditions.
The system is based on the idea that the human body has two hemispheres, one that controls blood flow and another that controls heart rate.
The blood pressure can be monitored using an electrocardiogram, a device that monitors blood pressure with electrodes attached to the chest and neck.
Patients with pre-existent heart problems can wear a mask and monitor their blood pressure using an app.
If a patient has symptoms of elevated blood pressure like high cholesterol, blood clots, and/or heart attacks, the app can warn them about the problem and send them to the doctor to treat.
The app can also use a blood sample to measure the patient and provide the patient with advice about possible treatment options.
Hemodynamic Monitor System is based in the US and the UK, but has been available in Japan, France, Germany, Italy, and South Korea.
The company claims it can detect blood pressure at up to 141,000 points and predicts that it will be used by doctors in the coming years.
The new device can also be used in hospitals, but the app is currently only available in the United States.
In a press release, Hemodynamic Manager, the company that developed the technology, said it is the most advanced of its kind, and that it is used in a variety of settings.
“As a result of this research, we have learned that the Hemodynamic Management system is a useful tool in monitoring and managing high blood pressures, especially when the patients have pre and post-existing cardiovascular diseases.
The most popular applications of the system include in-hospital monitoring, monitoring patients who are at high risk for cardiac events, and controlling cardiac ventricular fibrillation,” the company said.
“The device can detect the presence of elevated pressure in the patient based on electrocardiological data, such as electrocardiologist findings or a blood pressure reading.
This provides the physician with an objective indication of how the patient is feeling, which may be useful in assessing possible treatment of the elevated blood level,” it added.
The Hemodynamic manager also says that the device is highly reliable, able to monitor a patient’s heart rate and also track the patient in a laboratory.
The device is currently being tested in Japan and in the Netherlands, and it is expected to be ready for use in Europe in 2018.